Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 6 studies | 36% ± 17% | |
endothelial cell | 4 studies | 18% ± 4% | |
hepatocyte | 4 studies | 33% ± 16% | |
glutamatergic neuron | 4 studies | 33% ± 11% | |
oligodendrocyte | 4 studies | 20% ± 2% | |
respiratory goblet cell | 3 studies | 20% ± 3% | |
squamous epithelial cell | 3 studies | 45% ± 17% | |
epithelial cell | 3 studies | 38% ± 15% | |
GABAergic neuron | 3 studies | 32% ± 5% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 28% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2116.46 | 245 / 245 | 99% | 59.56 | 496 / 502 |
brain | 99% | 1479.73 | 2618 / 2642 | 100% | 21.90 | 702 / 705 |
kidney | 100% | 1453.98 | 89 / 89 | 97% | 27.36 | 874 / 901 |
breast | 100% | 2496.61 | 459 / 459 | 97% | 20.39 | 1083 / 1118 |
liver | 100% | 6530.21 | 226 / 226 | 97% | 34.51 | 392 / 406 |
intestine | 100% | 3354.84 | 966 / 966 | 96% | 41.50 | 507 / 527 |
pancreas | 98% | 860.23 | 321 / 328 | 98% | 31.82 | 175 / 178 |
lung | 100% | 1509.55 | 577 / 578 | 96% | 17.57 | 1110 / 1155 |
skin | 98% | 1381.33 | 1778 / 1809 | 96% | 24.96 | 454 / 472 |
esophagus | 100% | 2018.24 | 1445 / 1445 | 94% | 25.12 | 172 / 183 |
adrenal gland | 100% | 1753.49 | 258 / 258 | 93% | 21.07 | 215 / 230 |
stomach | 98% | 1100.52 | 352 / 359 | 93% | 29.64 | 266 / 286 |
uterus | 100% | 2169.78 | 170 / 170 | 90% | 22.31 | 415 / 459 |
thymus | 100% | 1267.81 | 652 / 653 | 90% | 10.60 | 542 / 605 |
bladder | 100% | 2267.19 | 21 / 21 | 86% | 22.46 | 435 / 504 |
ovary | 100% | 2324.79 | 180 / 180 | 53% | 4.99 | 230 / 430 |
adipose | 100% | 2317.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1906.71 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1250.22 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.63 | 1 / 1 |
muscle | 100% | 1023.03 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1038.71 | 841 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 18.38 | 42 / 45 |
eye | 0% | 0 | 0 / 0 | 79% | 8.41 | 63 / 80 |
lymph node | 0% | 0 | 0 / 0 | 76% | 12.29 | 22 / 29 |
peripheral blood | 55% | 637.32 | 512 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046835 | Biological process | carbohydrate phosphorylation |
GO_0006047 | Biological process | UDP-N-acetylglucosamine metabolic process |
GO_0046380 | Biological process | N-acetylneuraminate biosynthetic process |
GO_0006045 | Biological process | N-acetylglucosamine biosynthetic process |
GO_0005829 | Cellular component | cytosol |
GO_0008761 | Molecular function | UDP-N-acetylglucosamine 2-epimerase activity |
GO_0004553 | Molecular function | hydrolase activity, hydrolyzing O-glycosyl compounds |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0009384 | Molecular function | N-acylmannosamine kinase activity |
Gene name | GNE |
Protein name | UDP-N-acetylglucosamine-2-epimerase / N-acetylmannosamine kinase Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) (EC 3.2.1.183) (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase (EC 2.7.1.60) (ManAc kinase)] |
Synonyms | IBM2 GLCNE |
Description | FUNCTION: Bifunctional enzyme that possesses both UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities, and serves as the initiator of the biosynthetic pathway leading to the production of N-acetylneuraminic acid (NeuAc), a critical precursor in the synthesis of sialic acids. By catalyzing this pivotal and rate-limiting step in sialic acid biosynthesis, this enzyme assumes a pivotal role in governing the regulation of cell surface sialylation . Sialic acids represent a category of negatively charged sugars that reside on the surface of cells as terminal components of glycoconjugates and mediate important functions in various cellular processes, including cell adhesion, signal transduction, and cellular recognition . . |
Accessions | A0A7I2SU25 ENST00000447283.6 [Q9Y223-4] ENST00000543356.7 Q6QNY6 Q6QNY5 ENST00000642385.2 [Q9Y223-1] ENST00000396594.8 [Q9Y223-2] ENST00000539208.5 [Q9Y223-5] Q9Y223 Q6QNY7 |